ZCA1 SRB-1 (M1); february 28-march 1, 2019; DR. Zhiqiang ZOU: bethesda north marriott hotel & conference center; total hotel cost complies with HHS policy on promoting efficient spending as of…

Ended Awarded Last action

Contract number
75N91019F00081
Awardee
Awarding agency
Obligated
$15,358

Award facts

Contract value 100% obligated
$15,358.42 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Rockville, MD 20850, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00001 · To DE-obligate funds from FY2019 expiring lines following NIH oalm communication 24-16 (20231204) -$2,013
Original award $17,371

About this award

The National Cancer Institute (NCI), a civilian agency within the National Institutes of Health, awarded a Blanket Purchase Agreement (BPA) call to Bsrep II MBN LLC, doing business as the Bethesda North Marriott Hotel & Conference Center, on November 28, 2018, for a firm fixed-price contract valued at $15,358.42. The award was issued without a set-aside designation, indicating standard competitive procurement. The contract was ultimately completed on March 21, 2024, and supported a Scientific Review Board meeting held February 28–March 1, 2019, at the Bethesda North Marriott Hotel & Conference Center in Potomac, Maryland, under the direction of Dr. Zhiqiang Zou. The hotel cost complied with HHS spending efficiency policies in effect as of January 3, 2012.

Bsrep II MBN LLC is a subsidiary of Marriott International specializing in hospitality services for federal agencies, with particular expertise in supporting scientific peer review meetings and conferences for NIH institutes. The vendor has maintained an extensive track record of providing conference spaces, lodging, meeting facilities, and related services to the Department of Health and Human Services and multiple NIH centers, including the Center for Scientific Review and the National Institute of Arthritis and Musculoskeletal and Skin Diseases. The contract was de-obligated in December 2023 following National Institutes of Health Office of Administrative and Management Services communication 24-16 to clear expiring FY2019 funds.

Description

ZCA1 SRB-1 (M1); february 28-march 1, 2019; DR. Zhiqiang ZOU: bethesda north marriott hotel & conference center; total hotel cost complies with HHS policy on promoting efficient spending as of 1/3/2012

Quick answers

Who was awarded contract 75N91019F00081?

75N91019F00081 was awarded to Bsrep II MBN LLC by National Cancer Institute (National Institutes of Health) on November 28, 2018.

How much is contract 75N91019F00081 worth?

The government has obligated $15,358 on 75N91019F00081.

Is contract 75N91019F00081 an order under another contract?

Yes. 75N91019F00081 is a BPA call under HHSN263201500186B, a blanket purchase agreement.

Was contract 75N91019F00081 competed?

The extent of competition for 75N91019F00081 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award